Low-dose tocilizumab for relapsing giant cell arteritis in the elderly, fragile patient: Beyond the GiACTA trial

Autoimmun Rev. 2018 Dec;17(12):1265-1267. doi: 10.1016/j.autrev.2018.07.004. Epub 2018 Oct 12.
No abstract available

Keywords: GiACTA; Giant cell arteritis; Interlukin-6; Tocilizumab.

Publication types

  • Letter